Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 452 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Imetelstat Shows Durable Transfusion Independence and Disease-Modifying Activity in Heavily Transfused... December 11, 2023 FDA Grants Accelerated Approval to Tucatinib with Trastuzumab for Colorectal Cancer January 25, 2023 EMA Recommends Granting a Marketing Authorisation for Degarelix Accord September 14, 2023 Mapping Cancer Genomic Evolution Offers Insights into Tumor Development March 6, 2020 Load more HOT NEWS Hormone Therapy for Prostate Cancer? A Genetic Test Could Help Decide Mom Discovers She Has Breast Cancer After Weaning Twin Boys, Says... FDA Approves Melphalan As a Liver-Directed Treatment for Uveal Melanoma Identifying Safer Ways to Look for Recurrence After Testicular Cancer Surgery
